Market Tracker

06/23 5:16pm ET

Endo International PLC (NASDAQ:ENDP)

11.84
Delayed Data
As of Jun 23
 +0.19 / +1.63%
Today’s Change
9.70
Today|||52-Week Range
24.93
-28.11%
Year-to-Date
2 Recovering Biotech Names With Room to Run
Jun 23 / TheStreet.com - Paid Partner Content
Why Is Endo (ENDP) Down 4.7% Since the Last Earnings Report?
Jun 13 / Zacks.com - Paid Partner Content
BioDelivery Inks New Contract with CVS/Caremark, Shares Up
Jun 22 / Zacks.com - Paid Partner Content
Company News for June 12, 2017
Jun 12 / Zacks.com - Paid Partner Content
Is Endo International (ENDP) a Great Stock for Value Investors?
Jun 16 / Zacks.com - Paid Partner Content
Ohio blames drugmakers for fueling opioid crisis
Jun 01 / CNNMoney.com

Today’s Trading

Previous close11.65
Today’s open11.60
Day’s range11.46 - 11.88
Volume6,429,244
Average volume (3 months)8,429,508
Market cap$2.6B
Dividend yield--
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-96.37%
Earnings growth (this year)-24.22%
Earnings growth (next 5 years)-9.99%
Revenue growth (last year)+22.69%
P/E ratioNM
Price/Sales0.91
Price/Book0.98

Competitors

 Today’s
change
Today’s
% change
GWPHGW Pharmaceuticals P...+0.90+0.87%
LGNDLigand Pharmaceutica...+0.74+0.60%
AXONAxovant Sciences Ltd-0.13-0.54%
MDCOMedicines Co+0.45+1.18%
Data as of 4:01pm ET, 06/23/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)$0.71
Annual revenue (last year)$4.0B
Annual profit (last year)-$3.3B
Net profit margin-80.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul V. Campanelli
Chief Operating Officer &
Executive Vice President
Terrance J. Coughlin
Corporate headquarters
Dublin, Dublin

Forecasts